Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Eisai s.r.l

Femme et Homme Max 99 ans
Eisai s.r.l MAJ Il y a 4 ans

A superiority, randomized, open-label, multi-center study to compare the efficacy and safety of adjunctive zonisamide vs replacement with zonisamide of the last added antiepileptic drug in patients with partial onset seizures The primary objective of this study is to assess, in patients who respond to zonisamide added as third drug after failure of a two-drug combination therapy, the safety and efficacy of the triple thera...

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations